Digital Therapeutic Devices Market

Digital Therapeutic Devices Market (Product - Pain Management Devices, Rehabilitation Devices, Respiratory Therapy Devices and Insulin Pumps; Application – Preventive (Pre Diabetes, Obesity, and Smoking Cessation) and Treatment/Care (Diabetes, Cardiovascular Diseases, Central Nervous System Disease, Respiratory Diseases, Musculoskeletal Diseases, and Medication Adherence); End-user - B2C(Patients and Caregivers) and B2B(Providers, Payers, Employers, and Pharmaceutical Companies)) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025

Global Digital Therapeutic Devices Market: Snapshot

In a highly competitive global digital therapeutic devices market, savvy players are focused on collaborations and partnerships to improve their technical expertise for competitive gains. Established players are also tapping into the emerging economies of Asia Pacific that have vast growth potential in the digital therapeutic devices space.

The global digital therapeutic devices market is primarily driven by the rising use of technology for treating medical conditions. The demand for technologically advanced products for treating medical conditions coupled with rising disposable incomes is positively influencing the global digital therapeutic devices market. Several governments are also supporting the adoption of digital therapeutic devices that marks a significant change from traditional healthcare practices.

On the downside, the high price factor and risk of data breach are slowing the adoption of digital therapeutic devices.

According to projections by Transparency Market Research (TMR), the global digital therapeutic devices market will expand at impressive CAGR of 15.6% during the 2017-2025 forecast period. At this pace, the market will attract a revenue valuation of US$2,082.3 mn by the end of 2025 from US$590.8 mn in 2016.

Global Digital Therapeutic Devices Market Revenue

Treatment/Care Application Segment to Remain Attractive through 2025

Based on product, the global digital therapeutic devices market has been segmented into pain management devices, respiratory therapy devices, rehabilitation devices, and insulin pumps. Among them, the segment of insulin pumps constituted the leading market share in 2016 due to the increasing prevalence of diabetes. In terms of application, the digital therapeutic devices market has been segmented into preventive and treatment/care. Of the two, treatment/care is anticipated to hold the leading share and display a significant growth rate over the forecast period.

The segments of the global digital therapeutic devices market depending upon end user are B2C and B2B. While B2C is further segmented into patients and caregivers, B2B is sub-segmented into providers, payers, employers, pharmaceutical companies, and others. B2B held the leading market share in 2016 on the back of increasing adoption of digital therapeutic devices by employers and health insurance companies for ease of processing medical claims.

Popularity of Growth Funding Initiatives Make North America Leader

Geographically, the report gauges the potential of digital therapeutic devices market in the regions of North America, Asia Pacific, Europe, Latin America, and the Middle East and Africa. In 2016, North America accounted for the leading share in the global digital therapeutic devices market. The early adoption of technology coupled with increasing investment in digital therapeutic devices companies through government funding, venture capitalists, and mergers and acquisitions are supporting the growth of this regional market. For example, in March 2017, Livongo Health – the developer of an app for diabetes management and the developer of a cellular-connected blood glucose meter raised US$52.5 million by growth funding.

The Europe market for digital therapeutic devices market is predominantly led by Germany, France, Spain, the U.K., and Italy. Amongst them, the U.K. and Germany constituted the leading share in this regional market. Increasing prevalence of chronic diseases such as cancer, diabetes, and obesity and government initiatives for adoption of technology for treating medical conditions are contributing to the growth of Europe digital therapeutic devices market.

However, Asia Pacific is expected to display the leading growth rate over the forecast period. Increasing penetration of smartphone and government initiatives to promote the adoption of technology for treating medical conditions is likely to propel the growth of this regional market.

Leading companies in the global digital therapeutic devices market include Proteus Digital Health, WellDoc Inc., Noom Inc., Propeller Health, BiogeniQ Inc., Claritas MindSciences, Jintronix Inc., Zest Health LLC, HealthMine Inc., BioTelemetry Inc., Digital Twine health Inc., Firstbeat Technologies Ltd, Big Health, Dthera Sciences, Virta Health Corp, Pear Therapeutics Inc., Blue Mesa, Meru Health Inc., Canary Health, Glooko Inc., Nanobiosys Inc., Digital Therapeutics, Omada Health Inc., Ginger. Io Inc., Livongo Health, and 2Morrow Inc.

Efficacy for treatment of host of Medical Conditions boosts Digital Therapeutic Devices Market

Exponential rise in demand for technologically advanced medical services is creating opportunities in the digital therapeutic devices market. Digital therapeutic devices are available for a host of medical conditions with a product range, which includes pain management devices, rehabilitation devices, respiratory therapy devices, and insulin pumps. Among them, insulin pumps accounts for leading share in the digital therapeutic devices market.

Rising burden on healthcare institutions to serve large number of patients with chronic conditions is resulting in adoption of digital therapeutic devices. The use of digital therapeutic devices reduces dependency on human personnel to provide medical care through the course of treatment.

Emergence of super specialty and multispecialty healthcare institutions in developing countries is boosting the digital therapeutic devices market. Due to substantial funding from private trusts that run these healthcare institutions, these institutions are usually equipped with technologically advanced medical devices and boast state-of-the-art infrastructure. This indirectly fuels the digital therapeutic devices market.

Digital therapeutic devices are primarily used for preventive care and for treatment purpose. Of the two, treatment application segment holds larger share in the digital therapeutic devices market. Meanwhile, digital therapeutic devices find use for B2B and B2C end-use segments; the former is sub-segmented into providers, employers, payers, pharmaceutical companies, and others, and the latter is divided into patients and caregivers.

North America is the leading region among other key regions in the digital therapeutic devices. Early adoption of technology and increasing investment of governments for adoption of digital therapeutic devices in public healthcare institutions is favorable to the digital therapeutic devices market in the region. The region being home to some large players in the digital therapeutic devices market that are engaged in R&D and business collaborations further creates opportunities in the digital therapeutic devices market in North America.

Powered by the U.K. and Germany, Europe holds significant share in the digital therapeutic devices market.

Section 1 Preface 
1.1 Report Scope and Market Segmentation 
1.2 Research Highlights

Section 2 Assumptions and Research Methodology 
2.1 Research Methodology

Section 3 Executive Summary
3.1 Global Digital Therapeutic Devices Market Snapshot
3.2 Global Digital Therapeutic Devices Market Size ($ Mn) and Distribution, by Geography, 2017 and 2025

Section 4 Market Overview
4.1 Overview
4.2 Global Digital Therapeutic Devices Market: Porter's Analysis 
4.3 Global Digital Therapeutic Devices Market Size (US$ Mn) Forecast, 2015–2025
4.4 Global Digital Therapeutic Devices Market Outlook

Section 5 Market Dynamic
5.1 Drivers
      5.1.1 Increasing Government Initiatives
      5.1.2 Strategic Acquisitions enable Product Distribution in Other Regions, and also strengthening their Presence
      5.1.3 Rising incidence of Diabetes, Cardiovascular Diseases and other Chronic Diseases
      5.1.4 Increasing Collaborations between Companies for Technological Advancements
      5.1.5 Increasing Adoption of Digital Therapeutic Devices Product by Health Care Providers
5.2 Restrains
      5.2.1 High Costs Associated with Installation
      5.2.2 Cyber Threat 
5.3 Opportunities
      5.3.1 Adoption of cloud-based systems by health care organization and hospitals
      5.3.2 Penetration of smartphones in the health care sector & increase in demand for mobile apps
5.4 Trends
      5.4.1 Increasing adoption of cloud-based systems 
      5.4.2 Virtualization technologies and technological advancements add new dimension to health care IT
5.5 Digital Therapeutics Business, Opportunities and Entry Barriers for New Market Entrants - 2016
5.6 Qualitative Information on Business Models in Digital Therapeutic Devices Market 
5.7 Traditional Business Models: Challenges to Traditional Business models
5.8 New Digital Therapeutic Devices Business Models
5.9 Adoption of Digital Therapeutic Devicescare by End-users 
5.10 Impact Factors for Digital Therapeutics Demand 
5.11 Global Health Care Expenditure, by Major Countries 
5.12 Digital Medicine Business Model 
5.13 Factors Increasing Traction of Digital Therapeutics Products 
      5.13.1 Health Care Costs
      5.13.2 Value-based Payment Models
      5.13.3 Venture Funding
      5.13.4 Others

Section 6 Global Digital Therapeutic Devices Market Analysis, by Product
6.1 Introduction
6.2 Global Digital Therapeutic Devices Market Value Share Analysis, by Product
6.3 Digital Therapeutic Devices Market Analysis, by Product
      6.3.1 Pain management devices
      6.3.2 Rehabilitation devices
      6.3.3 Respiratory therapy devices
      6.3.4 Insulin Pumps
      6.4 Global Digital Therapeutic Devices Market Attractiveness Analysis, by Product

Section 7 Global Digital Therapeutic Devices (Digital Therapeutic Devices) Market Analysis, by Application
7.1 Introduction
7.2 Global Digital Therapeutic Devices (Digital Therapeutic Devices) Market Value Share Analysis, by Application
7.3 Global Digital Therapeutic Devices (Digital Therapeutic Devices) Market Analysis, by Application
      7.3.1 Preventive
              7.3.1.1 Pre diabetes
              7.3.1.2 Obesity
              7.3.1.3 Smoking Cessation
              7.3.1.4 Others
      7.3.2 Treatment/Care
              7.3.2.1 Diabetes
              7.3.2.2 Cardiovascular Diseases
              7.3.2.3 Central Nervous System Disease
              7.3.2.4 Respiratory Diseases
              7.3.2.5 Musculoskeletal Diseases
              7.3.2.6 Medication Adherence
              7.3.2.7 Others

Section 8 Global Digital Therapeutic Devices Market Analysis, by End-user
8.1 Introduction
8.2 Global Digital Therapeutic Devices Market Value Share Analysis, by End-user
8.3 Global Digital Therapeutic Devices Market Analysis, by End-user
      8.3.1 B2C
              8.3.1.1 Patients
              8.3.1.2 Caregivers
      8.3.2 B2B
              8.3.2.1 Providers
              8.3.2.2 Payers
              8.3.2.3 Employers
              8.3.2.4 Pharmaceutical Companies
              8.3.2.5 Others
8.4 Global Digital Therapeutic Devices Market Attractiveness Analysis, by End-user

Section 9 Global Digital Therapeutic Devices Market Analysis, by Region
9.1 Global Digital Therapeutic Devices Market Snapshot, by Country
9.2 Global Digital Therapeutic Devices Market Value Share Analysis, by Region
9.3 Digital Therapeutic Devices Market Forecast, by Region
9.4 Digital Therapeutic Devices Market Attractiveness Analysis, by Region

Section 10 North America Digital Therapeutic Devices Market Analysis
10.1 Key Findings
10.2 North America Digital Therapeutic Devices Market Overview
10.3 North America Digital Therapeutic Devices Market Value Share Analysis, by Product
10.4 North America Market Size (US$ Mn) Forecast, by Product, 2017–2025
      10.4.1 Pain management devices
      10.4.2 Rehabilitation devices
      10.4.3 Respiratory therapy devices
      10.4.4 Insulin Pumps
10.5 North America Digital Therapeutic Devices (Digital Therapeutic Devices) Market Value Share Analysis, by Application
10.6 North America Market Size (US$ Mn) Forecast, by Application (Digital Therapeutic Devices) 2017–2025
      10.6.1 Preventive
              10.6.1.1 Pre diabetes
              10.6.1.2 Obesity
              10.6.1.3 Smoking Cessation
              10.6.1.4 Others
      10.6.2 Treatment/Care
              10.6.2.1 Diabetes
              10.6.2.2 Cardiovascular Diseases
              10.6.2.3 Central Nervous System Disease
              10.6.2.4 Respiratory Diseases
              10.6.2.5 Musculoskeletal Diseases
              10.6.2.6 Medication Adherence
              10.6.2.7 Others
10.7 North America Digital Therapeutic Devices Market Value Share Analysis, by End-user
10.8 North America Market Size (US$ Mn) Forecast, by End-user 2017–2025
      10.8.1 B2C
              10.8.1.1 Patients
              10.8.1.2 Caregivers
      10.8.2 B2B
              10.8.2.1 Providers
              10.8.2.2 Payers
              10.8.2.3 Employers
              10.8.2.4 Pharmaceutical Companies
              10.8.2.5 Others
10.9 North America Market Value Share Analysis, by Country
10.10 North America Market Size (US$ Mn) Forecast, by Country, 2017–2025
      10.10.1 U.S.
      10.10.2 Canada
10.11 Market Attractiveness Analysis
      10.11.1 By Product
      10.11.2 By Application 
      10.11.3 By End User
      10.11.4 By Country

Section 11 Europe Digital Therapeutic Devices Market Analysis
11.1 Key Findings
11.2 Europe Digital Therapeutic Devices Market Overview
11.3 Europe Digital Therapeutic Devices Market Value Share Analysis, by Product
11.4 Europe Market Size (US$ Mn) Forecast, by Product, 2017–2025
      11.4.1 Pain management devices
      11.4.2 Rehabilitation devices
      11.4.3 Respiratory therapy devices
      11.4.4 Insulin Pumps
11.5 Europe Digital Therapeutic Devices (Digital Therapeutic Devices) Market Value Share Analysis, by Application
11.6 Europe Market Size (US$ Mn) Forecast, by Application (Digital Therapeutic Devices) 2017–2025
      11.6.1 Preventive
              11.6.1.1 Pre diabetes
              11.6.1.2 Obesity
              11.6.1.3 Smoking Cessation
11.6.1.4 Others
      11.6.2 Treatment/Care
              11.6.2.1 Diabetes
              11.6.2.2 Cardiovascular Diseases
              11.6.2.3 Central Nervous System Disease
              11.6.2.4 Respiratory Diseases
              11.6.2.5 Musculoskeletal Diseases
              11.6.2.6 Medication Adherence
              11.6.2.7 Others
11.7 Europe Digital Therapeutic Devices Market Value Share Analysis, by End-user
11.8 Europe Market Size (US$ Mn) Forecast, by End-user 2017–2025
      11.8.1 B2C
              11.8.1.1 Patients
              11.8.1.2 Caregivers
      11.8.2 B2B
              11.8.2.1 Providers
              11.8.2.2 Payers
              11.8.2.3 Employers
              11.8.2.4 Pharmaceutical Companies
              11.8.2.5 Others
11.9 Europe Market Value Share Analysis, by Country
11.10 Europe Market Size (US$ Mn) Forecast, by Country, 2017–2025
      11.10.1 U.K.
      11.10.2 Germany
      11.10.3 France
      11.10.4 Italy
      11.10.5 Spain
      11.10.6 Rest of Europe
11.11 Market Attractiveness Analysis
      11.11.1 By Product
      11.11.2 By Application 
      11.11.3 By End User
      11.11.4 By Country

Section 12 Asia Pacific Digital Therapeutic Devices Market Analysis
12.1 Key Findings
12.2 Asia Pacific Digital Therapeutic Devices Market Overview
12.3 Asia Pacific Digital Therapeutic Devices Market Value Share Analysis, by Product
12.4 Asia Pacific Market Size (US$ Mn) Forecast, by Product, 2017–2025
      12.4.1 Pain management devices
      12.4.2 Rehabilitation devices
      12.4.3 Respiratory therapy devices
      12.4.4 Insulin Pumps
12.5 Asia Pacific Digital Therapeutic Devices (Digital Therapeutic Devices) Market Value Share Analysis, by Application
12.6 Asia Pacific Market Size (US$ Mn) Forecast, by Application (Digital Therapeutic Devices) 2017–2025
      12.6.1 Preventive
              12.6.1.1 Pre diabetes
              12.6.1.2 Obesity
              12.6.1.3 Smoking Cessation
              12.6.1.4 Others
      12.6.2 Treatment/Care
              12.6.2.1 Diabetes
              12.6.2.2 Cardiovascular Diseases
              12.6.2.3 Central Nervous System Disease
              12.6.2.4 Respiratory Diseases
              12.6.2.5 Musculoskeletal Diseases
              12.6.2.6 Medication Adherence
              12.6.2.7 Others
12.7 Asia Pacific Digital Therapeutic Devices Market Value Share Analysis, by End-user
12.8 Asia Pacific Market Size (US$ Mn) Forecast, by End-user 2017–2025
      12.8.1 B2C
              12.8.1.1 Patients
              12.8.1.2 Caregivers
      12.8.2 B2B
              12.8.2.1 Providers
              12.8.2.2 Payers
              12.8.2.3 Employers
              12.8.2.4 Pharmaceutical Companies
              12.8.2.5 Others
12.9 Asia Pacific Market Value Share Analysis, by Country
12.10 Asia Pacific Market Size (US$ Mn) Forecast, by Country, 2017–2025
      12.10.1 China
      12.10.2 Japan
      12.10.3 Rest of Asia Pacific
12.11 Market Attractiveness Analysis
      12.11.1 By Product
      12.11.2 By Application 
      12.11.3 By End User
      12.11.4 By Country

Section 13 Latin America Digital Therapeutic Devices Market Analysis
13.1 Key Findings
13.2 Latin America Digital Therapeutic Devices Market Overview
13.3 Latin America Digital Therapeutic Devices Market Value Share Analysis, by Product
13.4 Latin America Market Size (US$ Mn) Forecast, by Product, 2017–2025
      13.4.1 Pain management devices
      13.4.2 Rehabilitation devices
      13.4.3 Respiratory therapy devices
      13.4.4 Insulin Pumps
13.5 Latin America Digital Therapeutic Devices (Digital Therapeutic Devices) Market Value Share Analysis, by Application
13.6 Latin America Market Size (US$ Mn) Forecast, by Application (Digital Therapeutic Devices) 2017–2025
      13.6.1 Preventive
              13.6.1.1 Pre diabetes
              13.6.1.2 Obesity
              13.6.1.3 Smoking Cessation
              13.6.1.4 Others
      13.6.2 Treatment/Care
              13.6.2.1 Diabetes
              13.6.2.2 Cardiovascular Diseases
              13.6.2.3 Central Nervous System Disease
              13.6.2.4 Respiratory Diseases
              13.6.2.5 Musculoskeletal Diseases
              13.6.2.6 Medication Adherence
              13.6.2.7 Others
13.7 Latin America Digital Therapeutic Devices Market Value Share Analysis, by End-user
13.8 Latin America Market Size (US$ Mn) Forecast, by End-user 2017–2025
      13.8.1 B2C
              13.8.1.1 Patients
              13.8.1.2 Caregivers
      13.8.2 B2B
              13.8.2.1 Providers
              13.8.2.2 Payers
              13.8.2.3 Employers
              13.8.2.4 Pharmaceutical Companies
              13.8.2.5 Others
13.9 Market Attractiveness Analysis
      13.9.1 By Product
      13.9.2 By Application
      13.9.3 By End User

Section 14 Middle East & Africa Digital Therapeutic Devices Market Analysis
14.1 Key Findings
14.2 Middle East & Africa Digital Therapeutic Devices Market Overview
14.3 Middle East & Africa Digital Therapeutic Devices Market Value Share Analysis, by Product
14.4 Middle East & Africa Market Size (US$ Mn) Forecast, by Product, 2017–2025
      14.4.1 Pain management devices
      14.4.2 Rehabilitation devices
      14.4.3 Respiratory therapy devices
      14.4.4 Insulin Pumps
14.5 Middle East & Africa Digital Therapeutic Devices (Digital Therapeutic Devices) Market Value Share Analysis, by Application
14.6 Middle East & Africa Market Size (US$ Mn) Forecast, by Application (Digital Therapeutic Devices) 2017–2025
      14.6.1 Preventive
              14.6.1.1 Pre diabetes
              14.6.1.2 Obesity
              14.6.1.3 Smoking Cessation
              14.6.1.4 Others
      14.6.2 Treatment/Care
              14.6.2.1 Diabetes
              14.6.2.2 Cardiovascular Diseases
              14.6.2.3 Central Nervous System Disease
              14.6.2.4 Respiratory Diseases
              14.6.2.5 Musculoskeletal Diseases
              14.6.2.6 Medication Adherence
              14.6.2.7 Others
14.7 Middle East & Africa Digital Therapeutic Devices Market Value Share Analysis, by End-user
14.8 Middle East & Africa Market Size (US$ Mn) Forecast, by End-user 2017–2025
      14.8.1 B2C
              14.8.1.1 Patients
              14.8.1.2 Caregivers
      14.8.2 B2B
              14.8.2.1 Providers
              14.8.2.2 Payers
              14.8.2.3 Employers
              14.8.2.4 Pharmaceutical Companies
              14.8.2.5 Others
14.9 Market Attractiveness Analysis
      14.9.1 By Product
      14.9.2 By Application
      14.9.3 By End User

Section 15 Company Profiles
15.1 Company Share Analysis
15.2 Company Profiles
      15.2.1 Proteus Digital Therapeutic Devices 
              15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
              15.2.1.2. Revenue Model
              15.2.1.3. Product Portfolio
              15.2.1.4. SWOT Analysis
              15.2.1.5. Strategic Overview
              15.2.1.6. Funding Overview
      15.2.2 Omada Health, Inc. 
              15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
              15.2.2.2. Revenue Model
              15.2.2.3. Product Portfolio
              15.2.2.4. SWOT Analysis
              15.2.2.5. Strategic Overview
              15.2.2.6. Funding Overview
      15.2.3 WellDoc, Inc. 
              15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
              15.2.3.2. Product Portfolio
              15.2.3.3. SWOT Analysis
              15.2.3.4. Strategic Overview
      15.2.4 Livongo Health 
              15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
              15.2.4.2. Product Portfolio
              15.2.4.3. SWOT Analysis
              15.2.4.4. Strategic Overview
              15.2.4.5. Funding Overview
      15.2.5 Noom, Inc. 
              15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
              15.2.5.2. Product Portfolio
              15.2.5.3. SWOT Analysis
              15.2.5.4. Strategic Overview
              15.2.5.5. Funding Overview
      15.2.6 Ginger.io, Inc. 
              15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
              15.2.6.2. Product Portfolio
              15.2.6.3. SWOT Analysis
              15.2.6.4. Strategic Overview
      15.2.7 Propeller Health 
              15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
              15.2.7.2. Product Portfolio
              15.2.7.3. SWOT Analysis
              15.2.7.4. Strategic Overview
              15.2.7.5. Funding Overview
      15.2.8 2Morrow, Inc. 
              15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
              15.2.8.2. Product Portfolio
              15.2.8.3. SWOT Analysis
              15.2.8.4. Strategic Overview
      15.2.9 Canary Health 
              15.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
              15.2.9.2. Product Portfolio
              15.2.9.3. SWOT Analysis
              15.2.9.4. Strategic Overview
      15.2.10 Mango Health 
              15.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
              15.2.10.2. Product Portfolio
              15.2.10.3. SWOT Analysis
              15.2.10.4. Strategic Overview
              15.2.10.5. Funding Overview
      15.2.11 BiogeniQ Inc. 
              15.2.11.1. Company Overview (HQ, Business Segments, Employee Strength)
              15.2.11.2. Product Portfolio
              15.2.11.3. SWOT Analysis
              15.2.11.4. Strategic Overview
      15.2.12 Twine Health, Inc. 
              15.2.12.1. Company Overview (HQ, Business Segments, Employee Strength)
              15.2.12.2. Product Portfolio
              15.2.12.3. SWOT Analysis
              15.2.12.4. Strategic Overview
              15.2.13 Glooko, Inc. 
      15.2.13.1. Company Overview (HQ, Business Segments, Employee Strength)
              15.2.13.2. Product Portfolio
              15.2.13.3. SWOT Analysis
              15.2.13.4. Strategic Overview
              15.2.13.5. Funding Overview
      15.2.14 Firstbeat Technologies Ltd 
              15.2.14.1. Company Overview (HQ, Business Segments, Employee Strength)
              15.2.14.2. Product Portfolio
              15.2.14.3. SWOT Analysis
              15.2.14.4. Strategic Overview
      15.2.15 Claritas MindSciences
              15.2.15.1. Company Overview (HQ, Business Segments, Employee Strength)
              15.2.15.2. Product Portfolio
              15.2.15.3. SWOT Analysis
              15.2.15.4. Strategic Overview
      15.2.16 Big Health 
              15.2.16.1. Company Overview (HQ, Business Segments, Employee Strength)
              15.2.16.2. Product Portfolio
              15.2.16.3. SWOT Analysis
              15.2.16.4. Strategic Overview
              15.2.16.5. Revenue Model
      15.2.17 Nanobiosym, Inc. 
              15.2.17.1. Company Overview (HQ, Business Segments, Employee Strength)
              15.2.17.2. Product Portfolio
              15.2.17.3. SWOT Analysis
              15.2.17.4. Strategic Overview
      15.2.18 Dthera Sciences 
              15.2.17.1. Company Overview (HQ, Business Segments, Employee Strength)
              15.2.17.2. Financial Overview
              15.2.17.3. Product Portfolio
              15.2.17.4. SWOT Analysis
              15.2.17.5. Strategic Overview
      15.2.19 Jintronix, Inc.
              15.2.19.1. Company Overview (HQ, Business Segments, Employee Strength)
              15.2.19.2. Product Portfolio
              15.2.19.3. SWOT Analysis
              15.2.19.4. Strategic Overview
              15.2.19.5. Funding Overview
      15.2.20 Virta Health Corp 
              15.2.20.1. Company Overview (HQ, Business Segments, Employee Strength)
              15.2.20.2. Product Portfolio
              15.2.20.3. SWOT Analysis
              15.2.20.4. Strategic Overview
      15.2.21 Zest Health, LLC 
              15.2.21.1. Company Overview (HQ, Business Segments, Employee Strength)
              15.2.21.2. Product Portfolio
              15.2.21.3. SWOT Analysis
              15.2.21.4. Strategic Overview
              15.2.21.5. Funding Overview
      15.2.22 Meru Health, Inc.
              15.2.22.1. Company Overview (HQ, Business Segments, Employee Strength)
              15.2.22.2. Product Portfolio
              15.2.22.3. SWOT Analysis
              15.2.22.4. Strategic Overview
              15.2.22.5. Funding Overview
      15.2.23 HealthMine, Inc. 
              15.2.23.1. Company Overview (HQ, Business Segments, Employee Strength)
              15.2.23.2. Product Portfolio
              15.2.23.3. SWOT Analysis
              15.2.23.4. Strategic Overview
              15.2.23.5. Funding Overview
      15.2.24 Pear Therapeutics, Inc. 
              15.2.24.1. Company Overview (HQ, Business Segments, Employee Strength)
              15.2.24.2. Product Portfolio
              15.2.24.3. SWOT Analysis
              15.2.24.4. Strategic Overview
              15.2.24.5. Funding Overview
      15.2.25 BioTelemetry, Inc. 
              15.2.25.1. Company Overview (HQ, Business Segments, Employee Strength)
              15.2.25.2. Financial Overview
              15.2.25.3. Product Portfolio
              15.2.25.4. SWOT Analysis
              15.2.25.5. Strategic Overview
      15.2.26 Blue Mesa Health 
              15.2.27.1. Company Overview (HQ, Business Segments, Employee Strength)
              15.2.27.2. Financial Overview
              15.2.27.3. Product Portfolio
              15.2.27.4. SWOT Analysis
              15.2.27.5. Strategic Overview
      15.2.27 Digital Therapeutics 
              15.2.27.1. Company Overview (HQ, Business Segments, Employee Strength)
              15.2.27.2. Financial Overview
              15.2.27.3. Product Portfolio
              15.2.27.4. SWOT Analysis
              15.2.27.5. Strategic Overview
15.3 M&A Deals - Digital Health
      15.3.1 M&A Deals in the Digital Therapeutic Devices Market (2015) 
      15.3.2 M&A Deals in the Digital Therapeutic Devices Market (2016) 
      15.3.3 M&A Deals in the Digital Therapeutic Devices Market (2015)
15.4 Funding Deals - Digital Health
      15.4.1 Funding Deals in the Digital Therapeutic Devices Market (2015) 
      15.4.2 Funding Deals in the Digital Therapeutic Devices Market (2016) 
      15.4.3 Funding Deals in the Digital Therapeutic Devices Market (2015)

List of Tables

Table 01: Diabetes Prevalence
Table 02: Data Security Breach
Table 03: Global Digital Therapeutic Devices Market Size (US$ Mn) Forecast, by Product, 2015–2025
Table 04: Global Digital Therapeutic Devices Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 05: Global Digital Therapeutic Devices Market Size (US$ Mn) Forecast, by Application (Preventive), 2015–2025
Table 06: Global Digital Therapeutic Devices Market Size (US$ Mn) Forecast, by Application (Treatment/Care),
Table 07: Global Digital Therapeutic Devices Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 08: Global B2C Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 09: Global B2B Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 10: Global Digital Therapeutic Devices Market Size (US$ Mn) Forecast, by Region, 2015–2025
Table 11: North America Digital Therapeutic Devices Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 12: North America Digital Therapeutic Devices Market Size (US$ Mn) Forecast, by Product, 2015–2025
Table 13: North America Digital Therapeutic Devices Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 14: North America Digital Therapeutic Devices Application Market Size (US$ Mn) Forecast, by Preventive, 2015–2025
Table 15: North America Digital Therapeutic Devices Application Market Size (US$ Mn) Forecast, by Treatment/Care, 2015–2025
Table 16: North America Digital Therapeutic Devices Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 17: North America Digital Therapeutic Devices Market Size (US$ Mn) Forecast, by End-user (B2C), 2015–2025
Table 18: North America Digital Therapeutic Devices Market Size (US$ Mn) Forecast, by End-user (B2B), 2015–2025
Table 19: Europe Digital Therapeutic Devices Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 20: Europe Digital Therapeutic Devices Market Size (US$ Mn) Forecast, by Product, 2015–2025
Table 21: Europe Digital Therapeutic Devices Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 22: Europe Digital Therapeutic Devices Application Market Size (US$ Mn) Forecast, by Preventive, 2015–2025
Table 23: Europe Digital Therapeutic Devices Application Market Size (US$ Mn) Forecast, by Treatment/Care, 2015–2025
Table 24: Europe Digital Therapeutic Devices Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 25: Europe Digital Therapeutic Devices Market Size (US$ Mn) Forecast, by End-user (B2C), 2015–2025
Table 26: Europe Digital Therapeutic Devices Market Size (US$ Mn) Forecast, by End-user (B2B), 2015–2025
Table 27: Asia Pacific Digital Therapeutic Devices Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 28: Asia Pacific Digital Therapeutic Devices Market Size (US$ Mn) Forecast, by Product, 2015–2025
Table 29: Asia Pacific Digital Therapeutic Devices Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 30: Asia Pacific Digital Therapeutic Devices Application Market Size (US$ Mn) Forecast, by Preventive, 2015–2025
Table 31: Asia Pacific Digital Therapeutic Devices Application Market Size (US$ Mn) Forecast, by Treatment/Care, 2015–2025
Table 32: Asia Pacific Digital Therapeutic Devices Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 33: Asia Pacific Digital Therapeutic Devices Market Size (US$ Mn) Forecast, by End-user (B2C), 2015–2025
Table 34: Asia Pacific Digital Therapeutic Devices Market Size (US$ Mn) Forecast, by End-user (B2B), 2015–2025
Table 35: Latin America Digital Therapeutic Devices Market Size (US$ Mn) Forecast, by Product, 2015–2025
Table 36: Latin America Digital Therapeutic Devices Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 37: Latin America Digital Therapeutic Devices Application Market Size (US$ Mn) Forecast, by Preventive, 2015–2025
Table 38: Latin America Digital Therapeutic Devices Application Market Size (US$ Mn) Forecast, by Treatment/Care, 2015–2025
Table 39: Latin America Digital Therapeutic Devices Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 40: Latin America Digital Therapeutic Devices Market Size (US$ Mn) Forecast, by End-user (B2C), 2015–2025
Table 41: Latin America Digital Therapeutic Devices Market Size (US$ Mn) Forecast, by End-user (B2B), 2015–2025
Table 42: Middle East & Africa Digital Therapeutic Devices Market Size (US$ Mn) Forecast, by Product, 2015–2025
Table 43: Middle East & Africa Digital Therapeutic Devices Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 44: Middle East & Africa Digital Therapeutic Devices Application Market Size (US$ Mn) Forecast, by Preventive, 2015–2025
Table 45: Middle East & Africa Digital Therapeutic Devices Application Market Size (US$ Mn) Forecast, by Treatment/Care, 2015–2025
Table 46: Middle East & Africa Digital Therapeutic Devices Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 47: Middle East & Africa Digital Therapeutic Devices Market Size (US$ Mn) Forecast, by End-user (B2C), 2015–2025
Table 48: Middle East & Africa Digital Therapeutic Devices Market Size (US$ Mn) Forecast, by End-user (B2B), 2015–2025

List of Figures

Figure 01: Global Digital Therapeutic Devices Market Size (US$ Mn) Forecast, 2015–2025
Figure 02: Market Value Share, by Product (2016)
Figure 03: Market Value Share, by Application (2016)
Figure 04: Market Value Share, by End-user (2016)
Figure 05: Market Value Share, by Region (2016)
Figure 06: Global Digital Therapeutic Devices Market Value Share Analysis, by Product, 2017 and 2025
Figure 07: Global Digital Therapeutic Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Pain Management Devices, 2015–2025
Figure 08: Global Digital Therapeutic Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Rehabilitation Devices, 2015–2025
Figure 09: Global Digital Therapeutic Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Respiratory Therapy Devices, 2015–2025
Figure 10: Global Digital Therapeutic Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Insulin Pumps, 2015–2025
Figure 11: Global Wearable Devices Market Attractiveness Analysis, by Digital Therapeutic Devices, 2017–2025
Figure 12: Global Digital Therapeutic Devices Market Value Share Analysis, by Application, 2017 and 2025
Figure 13: Global Digital Therapeutic Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Preventive, 2015–2025
Figure 14: Global Digital Therapeutic Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Treatment/Care, 2015–2025
Figure 15: Global Digital Therapeutic Devices Market Value Share Analysis, by Preventive, 2017 and 2025
Figure 16: Global Digital Therapeutic Devices Market Value Share Analysis, by Application (Treatment/Care), 2017 and 2025
Figure 17: Global Digital Therapeutic Devices Market Attractiveness Analysis, by Application, 2017–2025
Figure 18: Global Digital Therapeutic Devices Market Attractiveness Analysis, by Preventive, 2017–2025 
Figure 19: Global Digital Therapeutic Devices Market Attractiveness Analysis, by Treatment/Care, 2017–2025
Figure 20: Global Digital Therapeutic Devices Market Value Share Analysis, by End-user, 2017 and 2025
Figure 21: Global Digital Therapeutic Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by B2C, 2015–2025
Figure 22: Global Digital Therapeutic Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by B2B, 2015–2025
Figure 23: Global B2C Market Value Share Analysis, by End-user, 2017 and 2025
Figure 24: Global B2B Market Value Share Analysis, by End-user, 2017 and 2025
Figure 25: Global Digital Therapeutic Devices Market Attractiveness Analysis, by End-user, 2017–2025
Figure 26: Global B2C Market Attractiveness Analysis, by End-user, 2017–025
Figure 27: Global B2B Market Attractiveness Analysis, by End-user, 2017–2025
Figure 28: Global Digital Therapeutic Devices Market Value Share Analysis, by Region, 2017 and 2025
Figure 29: Global Digital Therapeutic Devices Market Attractiveness Analysis, by Region, 2017–2025
Figure 30: North America Digital Therapeutic Devices Market Size
Figure 31: North America Market Attractiveness Analysis,
Figure 32: North America Market Value Share Analysis, by Country, 2017 and 2025
Figure 33: North America Digital Therapeutic Devices Market Value Share Analysis, by Product, 2017 and 2025
Figure 34: North America Digital Therapeutic Devices Market Value Share Analysis, by Application, 2017 and 2025
Figure 35: North America Digital Therapeutic Devices Application Market Value Share Analysis, by Treatment/Care, 2017 and 2025
Figure 36: North America Digital Therapeutic Devices Application Market Value Share Analysis, by Preventive, 2017 and 2025
Figure 37: North America Digital Therapeutic Devices Market Value Share Analysis, by End-user, 2017 and 2025
Figure 38: North America Digital Therapeutic Devices Market Value Share Analysis, by End-user (B2C), 2017 and 2025
Figure 39: North America Digital Therapeutic Devices Market Value Share Analysis, by End-user (B2B), 2017 and 2025
Figure 40: North America Digital Therapeutic Devices Market Attractiveness Analysis, by Product, 2017–2025
Figure 41: North America Digital Therapeutic Devices Market Attractiveness Analysis, by Application, 2017–2025
Figure 42: North America Digital Therapeutic Devices Market Attractiveness Analysis, by End User, 2017–2025
Figure 43: Europe Digital Therapeutic Devices Market Size (US$ Mn) Forecast, 2015–2025
Figure 44: Europe Digital Therapeutic Devices Market Attractiveness Analysis, by Country, 2017–2025
Figure 45: Europe Digital Therapeutic Devices Market Value Share Analysis by Country, 2017 and 2025
Figure 46: Europe Digital Therapeutic Devices Market Value Share Analysis, by Product, 2017 and 2025
Figure 47: Europe Digital Therapeutic Devices Market Value Share Analysis, by Application, 2017 and 2025
Figure 48: Europe Digital Therapeutic Devices Application Market Value Share Analysis, by Treatment/Care, 2017 and 2025
Figure 49: Europe Digital Therapeutic Devices Application Market Value Share Analysis, by Preventive, 2017 and 2025
Figure 50: Europe Digital Therapeutic Devices Market Value Share Analysis, by End-user, 2017 and 2025
Figure 51: Europe Digital Therapeutic Devices Market Value Share Analysis, by End-user (B2C), 2017 and 2025
Figure 52: Europe Digital Therapeutic Devices Market Value Share Analysis, by End-user (B2B), 2017 and 2025
Figure 53: Europe Digital Therapeutic Devices Market Attractiveness Analysis, by Product, 2017–2025
Figure 54: Europe Digital Therapeutic Devices Market Attractiveness Analysis, by Application, 2017–2025
Figure 55: Europe Digital Therapeutic Devices Market Attractiveness Analysis, by End User, 2017–2025
Figure 56: Asia Pacific Digital Therapeutic Devices Market Size (US$ Mn) Forecast, 2015–2025
Figure 57: Asia Pacific Market Attractiveness Analysis, by Country, 2017–2025
Figure 58: Asia Pacific Digital Therapeutic Devices Market Value Share Analysis, by Country, 2017 and 2025
Figure 59: Asia Pacific Digital Therapeutic Devices Market Value Share Analysis, by Product, 2017 and 2025
Figure 60: Asia Pacific Digital Therapeutic Devices Market Value Share Analysis, by Application, 2017 and 2025
Figure 61: Asia Pacific Digital Therapeutic Devices Application Market Value Share Analysis, by Treatment/Care, 2017 and 2025
Figure 62: Asia Pacific Digital Therapeutic Devices Application Market Value Share Analysis, by Preventive, 2017 and 2025
Figure 63: Asia Pacific Digital Therapeutic Devices Market Value Share Analysis, by End-user, 2017 and 2025
Figure 64: Asia Pacific Digital Therapeutic Devices Market Value Share Analysis, by End-user (B2C), 2017 and 2025
Figure 65: Asia Pacific Digital Therapeutic Devices Market Value Share Analysis, by End-user (B2B), 2017 and 2025
Figure 66: Asia Pacific Digital Therapeutic Devices Market Attractiveness Analysis, by Product, 2017–2025
Figure 67: Asia Pacific Digital Therapeutic Devices Market Attractiveness Analysis, by Application, 2017–2025
Figure 68: Asia Pacific Digital Therapeutic Devices Market Attractiveness Analysis, by End User, 2017–2025
Figure 69: Latin America Digital Therapeutic Devices Market Size
Figure 70: Latin America Digital Therapeutic Devices Market Value Share Analysis, by Product, 2017 and 2025
Figure 71: Latin America Digital Therapeutic Devices Market Value Share Analysis, by Application, 2017 and 2025
Figure 72: Latin America Digital Therapeutic Devices Application Market Value Share Analysis, by Treatment/Care, 2017 and 2025
Figure 73: Latin America Digital Therapeutic Devices Application Market Value Share Analysis, by Preventive, 2017 and 2025
Figure 74: Latin America Digital Therapeutic Devices Market Value Share Analysis, by End-user, 2017 and 2025
Figure 75: Latin America Digital Therapeutic Devices Market Value Share Analysis, by End-user (B2C), 2017 and 2025
Figure 76: Latin America Digital Therapeutic Devices Market Value Share Analysis, by End-user (B2B), 2017 and 2025
Figure 77: Latin America Digital Therapeutic Devices Market Attractiveness Analysis, by Product, 2017–2025
Figure 78: Latin America Digital Therapeutic Devices Market Attractiveness Analysis, by Application, 2017–2025
Figure 79: Latin America Digital Therapeutic Devices Market Attractiveness Analysis, by End User, 2017–2025
Figure 80: Middle East & Africa Digital Therapeutic Devices Market Size (US$ Mn) Forecast, 2015–2025
Figure 81: Middle East & Africa Digital Therapeutic Devices Market Value Share Analysis, by Product, 2017 and 2025
Figure 82: Middle East & Africa Digital Therapeutic Devices Market Value Share Analysis, by Application, 2017 and 2025
Figure 83: Middle East & Africa Digital Therapeutic Devices Application Market Value Share Analysis, by Treatment/Care, 2017 and 2025
Figure 84: Middle East & Africa Digital Therapeutic Devices Application Market Value Share Analysis, by Preventive, 2017 and 2025
Figure 85: Middle East & Africa Digital Therapeutic Devices Market Value Share Analysis, by End-user, 2017 and 2025
Figure 86: Middle East & Africa Digital Therapeutic Devices Market Value Share Analysis, by End-user (B2C), 2017 and 2025
Figure 87: Middle East & Africa Digital Therapeutic Devices Market Value Share Analysis, by End-user (B2B), 2017 and 2025
Figure 88: Middle East & Africa Digital Therapeutic Devices Market Attractiveness Analysis, by Product, 2017–2025
Figure 89: Middle East & Africa Digital Therapeutic Devices Market Attractiveness Analysis, by Application, 2017–2025
Figure 90: Middle East & Africa Digital Therapeutic Devices Market Attractiveness Analysis, by End User, 2017–2025

Copyright © Transparency Market Research, Inc. All Rights reserved